JAKARTA: PT Kalbe Farma, a leading Indonesian pharmaceutical group, has reported net sales of 6.015 trillion rupiah (RM1.74bil) in the first quarter of 2021, marking a year-on-year increase of 3.8% and failing to impress investors.
The group expressed optimism and projected an annual increase of 5% to 6% in both sales and net profit, resting its hopes, in large part, on business related to the Covid-19 pandemic.
Already a subscriber? Log in.
Subscribe to The Star Yearly Premium Plan for 30% off
Cancel anytime. Ad-free. Full access to Web and App.
Monthly Plan
RM 13.90/month
RM 9.73/month
Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.
Best Value
Annual Plan
RM 12.39/month
RM 8.63/month
Billed as RM 103.60 for the 1st year, RM 148 thereafter.
